Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Scholars @ UT Health San Antonio Inicio
Ayuda y preguntas frecuentes
El enlace se abre en una pestaña nueva
English
Español
Buscar contenido en Scholars @ UT Health San Antonio
Inicio
Perfiles
Unidades de investigación
Producción científica
Conjuntos de datos
Attention-deficit-hyperactivity disorder: An update
Julie A. Dopheide
,
Steven R. Pliszka
Department of Psychiatry & Behavioral Sciences
Producción científica
:
Review article
›
revisión exhaustiva
168
El enlace se abre en una pestaña nueva
Citas (Scopus)
Información general
Huella
Huella
Profundice en los temas de investigación de 'Attention-deficit-hyperactivity disorder: An update'. En conjunto forman una huella única.
Clasificar por
Ponderación
Alfabéticamente
Medicine and Dentistry
Attention Deficit Disorder
77%
Drug Therapy
44%
Patient with Attention Deficit Hyperactivity Disorder
44%
Child
44%
Adult
44%
Psychoeducation
33%
Analeptic
33%
Drug Abuse
33%
Prevalence
22%
Atomoxetine
22%
Combination Therapy
22%
Brain Region
22%
Growth
22%
Therapeutic Procedure
22%
Inpatient
22%
Preschooler
22%
Methylphenidate
11%
Diseases
11%
Polyunsaturated Fatty Acid
11%
Insomnia
11%
Age Groups
11%
Adverse Event
11%
Clonidine
11%
Ferritin
11%
Dopamine Agonist
11%
Acetic Acid Derivative
11%
Patient Population
11%
Antisocial Personality Disorder
11%
Bupropion
11%
Carnitine
11%
Brain Maturation
11%
Guanfacine
11%
Symptom
11%
Bradycardia
11%
Drug
11%
Chemotherapeutic Agent
11%
Iron Supplement
11%
Delinquency
11%
Abuse
11%
Adolescent
11%
Monitoring
11%
Sedation
11%
Pharmacology, Toxicology and Pharmaceutical Science
Attention Deficit Disorder
77%
Stimulant
33%
Prevalence
22%
Atomoxetine
22%
Methylphenidate
11%
Amphetamine
11%
Diseases
11%
Adverse Event
11%
Dopamine Receptor Stimulating Agent
11%
Acetic Acid Derivative
11%
Fish Oil
11%
Clonidine
11%
Drug
11%
Bupropion
11%
Bradycardia
11%
Ferritin
11%
Insomnia
11%
Guanfacine
11%
Antisocial Personality Disorder
11%
Polyunsaturated Fatty Acid
11%
Carnitine
11%
Death
11%
Symptom
11%
Conduct Disorder
11%
Neuroscience
Attention Deficit Hyperactivity Disorder
100%
Brain
33%
Atomoxetine
22%
Conduct Disorder
22%
Clonidine
11%
Amphetamine
11%
Dopaminergic
11%
Antisocial Personality Disorder
11%
Bupropion
11%
Ferritin
11%
Polyunsaturated Fatty Acid
11%
Guanfacine
11%
Methylphenidate
11%
Bradycardia
11%
Carnitine
11%
Adverse Effect
11%
Insomnia
11%
Psychology
Attention Deficit
77%
Children
44%
Treatment
22%
Adolescents
22%
Methylphenidate
11%
Amphetamine
11%
Inhibitory Control
11%
Behavioral Intervention
11%
Antisocial Personality Disorder
11%
Research
11%
Groups
11%
Delinquency
11%